Tofacitinib, An Inhibitor Of Janus Kinases (JAKs), Is Indicated For The Treatment Of Adult Patients With Moderately To Severely Active Rheumatoid Arthritis Who Have Had An Inadequate Response Or Intolerance To Methotrexate. It May Be Used As Monother ...Read More